Close

Search

Search Menu
Photonics Media Photonics Marketplace Photonics Spectra BioPhotonics Vision Spectra Photonics Showcase Photonics ProdSpec Photonics Handbook

TriPath Imaging Inc.

Facebook Twitter LinkedIn Email
TriPath Imaging Inc. of Burlington, N.C., has received the FDA’s 510(k) approval to use the Ki-67 cell proliferation biomarker with the Ventana Image Analysis System from Ventana Medical Systems Inc. of Tucson, Ariz. The biomarker enables pathologists to determine the percentage of tumor cells that are actively dividing with precise quantitative measurements of the biomarker’s expression in breast biopsy samples. The approach is expected to aid scientists in further investigations into the correlation between proliferation rate and survival.Read full article

Related content from Photonics Media



    ARTICLES


    PRODUCTS


    PHOTONICS HANDBOOK ARTICLES


    WHITEPAPERS


    WEBINARS


    PHOTONICS DICTIONARY TERMS


    MEDIA


    PHOTONICS BUYERS' GUIDE CATEGORIES


    COMPANIES
    BioPhotonics
    Jun 2006
    BiophotonicsBusinessRapidScan

    back to top
    Facebook Twitter Instagram LinkedIn YouTube RSS
    ©2023 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA, [email protected]

    Photonics Media, Laurin Publishing
    x Subscribe to BioPhotonics magazine - FREE!
    We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.